+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effect of liposome-encapsulated muramyl tripeptide phosphatidylethanolamine and interferon-gamma on Klebsiella pneumoniae infection in T-cell-deficient mice and in vitro



Effect of liposome-encapsulated muramyl tripeptide phosphatidylethanolamine and interferon-gamma on Klebsiella pneumoniae infection in T-cell-deficient mice and in vitro



Masihi, K N Infectious Disease and Therapy; Immunotherapy of infections: 225-234




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031094232

Download citation: RISBibTeXText


Related references

Involvement of T cells in enhanced resistance to Klebsiella pneumoniae septicemia in mice treated with liposome-encapsulated muramyl tripeptide phosphatidylethanolamine or gamma interferon. Infection and Immunity 66(5): 1962-1967, 1998

Modulation of nonspecific antimicrobial resistance of mice to Klebsiella pneumoniae septicemia by liposome-encapsulated muramyl tripeptide phosphatidylethanolamine and interferon-gamma alone or combined. Journal of Infectious Diseases 171(2): 385-392, 1995

Modulation of Nonspecific Antimicrobial Resistance of Mice to "Klebsiella pneumoniae" Septicemia by Liposome-Encapsulated Muramyl Tripeptide Phosphatidylethanolamine and Interferon- Alone or Combined. The Journal of Infectious Diseases 171(2): 385-392, 1995

Free versus liposome encapsulated muramyl tripeptide phosphatidylethanolamine in treatment of experimental klebsiella pneumoniae infection. Infection & Immunity 60(1): 95-101, 1992

Treatment of Klebsiella pneumoniae septicemia in normal and leukopenic mice by liposome-encapsulated muramyl tripeptide phosphatidylethanolamide. Antimicrobial Agents and ChemoTherapy 38(1): 147-150, 1994

Distribution and fate of free and liposome-encapsulated [3H]nor-muramyl dipeptide and [3H]muramyl tripeptide phosphatidylethanolamine in mice. Journal of Immunology 135(2): 1372-1377, 1985

Free verus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide and interferon-gamma in experimental infection with Listeria monocytogenes. Biotherapy 6(2): 113-124, 1993

Comparative interaction of free and liposome-encapsulated nor-muramyl dipeptide or muramyl tripeptide phosphatidylethanolamine (3H-labelled) with human blood monocytes. International Journal of Immunopharmacology 9(2): 141-150, 1987

Effect of systemic immunotherapy with liposome-encapsulated muramyl tripeptide phosphatidylethanolamine on lymphocyte locomotion through type I collagen. Proceedings of the American Association for Cancer Research Annual Meeting 35: 481, 1994

Impairment of lymphocyte locomotion in the tumor microenvironment and the effect of systemic immunotherapy with liposome-encapsulated muramyl-tripeptide-phosphatidylethanolamine. Cancer Immunology Immunotherapy. 40(1): 57-64, 1995

Liposome encapsulated muramyl tripeptide phosphatidylethanolamine for the treatment of osteosarcoma. Cancer Bulletin 43(2): 127-132, 1991

Free versus liposome-encapsulated muramyl tripeptide phosphatidylethanolamide (MTPPE) and interferon-y (IFN-y) in experimental infection with Listeria monocytogenes. BioTherapy 6(2): 113-124, 1993

Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (L-MTP-PE): a randomized clinical trial in dogs with mammary carcinoma. Anticancer Research 18(2a): 1015-1019, 1998

Effect of ibuprofen on monocyte activation by liposome-encapsulated muramyl tripeptide phosphatidylethanolamine (CGP 19835A): Can ibuprofen reduce fever and chills without compromising immune stimulation?. Cancer Immunology Immunotherapy 36(1): 45-51, 1993

Synergism of recombinant human interferon gamma with liposome-encapsulated muramyl tripeptide in activation of the tumoricidal properties of human monocytes. International Journal of Cancer 38(4): 495-500, 1986